Berlin, 26.04.2024 - The Management Board of M1 Kliniken AG today resolved to repurchase up to 1,000,000 shares of the Company in a total volume not exceeding EUR 12,600,000.00 (excluding incidental acquisition costs). The resolution is based on the authorisation of the Annual General Meeting of 9 July 2020 to acquire own shares. The buyback programme is to start on 29 April 2024 and be completed by the end of 25 April 2025 at the latest. The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company. The sole purpose of the share buyback programme is to use the repurchased shares for all purposes provided for in the authorisation resolution of the Company's Annual General Meeting of 9 July 2020 and for all other purposes permitted under the law governing the Company's shares.

The buy-back programme and its implementation shall take place in compliance with the requirements of the safe harbour regulations pursuant to Art. 5 para. 2 of the Market Abuse Regulation (EU) No. 596/2014 and Art. 2, 3 and 4 of the Delegated Regulation (EU) No. 2016/1052, with the exception of the purpose of the buy-back. This is broader than determined by Art. 5 para. 2 of the Market Abuse Regulation.

Berlin, 03.05.2024 - In the period from 29.04.2024 up to and including 03.05.2024, M1 Kliniken AG has acquired 17.017 shares in the context of its ongoing share buyback programme, which was published by notice dated 26.04.2024 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.

Shares were purchased as follows:

Date	Number of shares	Average price (EUR)
29.04.2024	4.458	13,31
30.04.2024	4.938	13,47
01.05.2024	n.a.	n.a.
02.05.2024	2.098	14,51
03.05.2024	5.523	15,00
Total	17.017

 

The total number of shares purchased in the context of the share buy-back program since 29.04.2024 through, and including, 03.05.2024 amounts to 17.017.

The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.

Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).

Berlin, 10.05.2024 - In the period from 06.05.2024 up to and including 10.05.2024, M1 Kliniken AG has acquired 28.948 shares in the context of its ongoing share buyback programme, which was published by notice dated 26.04.2024 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.

Shares were purchased as follows:

Date	Number of shares	Average price (EUR)
06.05.2024	0	0
07.05.2024	6.537	16,50
08.05.2024	7.118	16,00
09.05.2024	7.634	16,26
10.05.2024	7.659	16.36
Total	28.948

 

The total number of shares purchased in the context of the share buy-back program since 29.04.2024 through, and including, 10.05.2024 amounts to 45.965.

The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.

Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).

Berlin, 17.05.2024 - In the period from 13.05.2024 up to and including 17.05.2024, M1 Kliniken AG has acquired 40.744 shares in the context of its ongoing share buyback programme, which was published by notice dated 26.04.2024 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.

Shares were purchased as follows:

Date	Number of shares	Average price (EUR)
13.05.2024	7.810	16,05
14.05.2024	7.855	16,44
15.05.2024	8.031	16,54
16.05.2024	8.142	17,51
17.05.2024	8.906	17.68
Total	40.744

 

The total number of shares purchased in the context of the share buy-back program since 29.04.2024 through, and including, 17.05.2024 amounts to 86.709.

The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.

Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).

Berlin, 24.05.2024 - In the period from 20.05.2024 up to and including 24.05.2024, M1 Kliniken AG has acquired 54.088 shares in the context of its ongoing share buyback programme, which was published by notice dated 26.04.2024 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.

Shares were purchased as follows:

Date	Number of shares	Average price (EUR)
20.05.2024	9.466	18,13
21.05.2024	10.106	19,02
22.05.2024	11.144	19,26
23.05.2024	11.511	18,77
24.05.2024	11.861	19,82
Total	54.088

 

The total number of shares purchased in the context of the share buy-back program since 29.04.2024 through, and including, 24.05.2024 amounts to 140.797.

The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.

Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).

Berlin, 31.05.2024 - In the period from 27.05.2024 up to and including 31.05.2024, M1 Kliniken AG has acquired 60.550 shares in the context of its ongoing share buyback programme, which was published by notice dated 26.04.2024 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.

Shares were purchased as follows:

Date	Number of shares	Average price (EUR)
27.05.2024	6.086	20,50
28.05.2024	12.886	21,10
29.05.2024	13.342	20,39
30.05.2024	13.761	21,18
31.05.2024	14.475	21,20
Total	60.550

 

The total number of shares purchased in the context of the share buy-back program since 29.04.2024 through, and including, 31.05.2024 amounts to 201.347.

The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.

Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).

Berlin, 07.06.2024 - In the period from 03.06.2024 up to and including 07.06.2024, M1 Kliniken AG has acquired 73.385 shares in the context of its ongoing share buyback programme, which was published by notice dated 26.04.2024 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.

Shares were purchased as follows:

Date	Number of shares	Average price (EUR)
03.06.2024	14.439	21,39
04.06.2024	14.444	21,25
05.06.2024	14.676	21,77
06.06.2024	14.621	21,35
07.06.2024	15.205	20,28
Total	73.385

 

The total number of shares purchased in the context of the share buy-back program since 29.04.2024 through, and including, 07.06.2024 amounts to 274.732.

The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.

Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).

Berlin, 14.06.2024 - In the period from 10.06.2024 up to and including 14.06.2024, M1 Kliniken AG has acquired 84.239 shares in the context of its ongoing share buyback programme, which was published by notice dated 26.04.2024 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.

Shares were purchased as follows:

Date	Number of shares	Average price (EUR)
10.06.2024	16.063	21,25
11.06.2024	16.223	21,18
12.06.2024	17.011	20,81
13.06.2024	17.719	21,19
14.06.2024	17.223	20,90
Total	84.239

 

The total number of shares purchased in the context of the share buy-back program since 29.04.2024 through, and including, 14.06.2024 amounts to 358.971.

The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.

Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).